GoldState Music | $500,000,000 | (Apr 22, 2025)
CSignum | $8,021,670 | (Apr 22, 2025)
Terra Security | $7,500,000 | (Apr 22, 2025)
Certified by Founder
Lodge
Delphia Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/05/2024
- Series A
- $67,000,000
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.
- Industry Biotechnology Research
- Website https://www.delphiatx.com/
- LinkedIn https://www.linkedin.com/company/delphia-therapeutics/
Brellium | $13,700,000 | (Apr 22, 2025)
Spur | $4,500,000 | (Apr 22, 2025)
Cosmic Robotics | $4,000,000 | (Apr 22, 2025)
Capsule | $12,000,000 | (Apr 22, 2025)
Kenzo Security | $45,000,000 | (Apr 22, 2025)
Electra.aero | $115,000,000 | (Apr 22, 2025)
ROH | $9,000,000 | (Apr 22, 2025)
Booked it | $3,316,375 | (Apr 18, 2025)
Exaforce Inc. | $75,000,000 | (Apr 18, 2025)